Cargando…

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer

SIMPLE SUMMARY: High-grade serous ovarian carcinoma (HGSC) could be analyzed with a molecular stratification defined by different genomic instability signatures associated with specific mutational process and prognostic biomarkers. Immune infiltrate is known to be a robust biomarker in HGSC. We aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecuelle, Julie, Boidot, Romain, Mananet, Hugo, Derangère, Valentin, Albuisson, Juliette, Goussot, Vincent, Arnould, Laurent, Tharin, Zoé, Ray Coquard, Isabelle, Ghiringhelli, François, Truntzer, Caroline, Fumet, Jean-David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430641/
https://www.ncbi.nlm.nih.gov/pubmed/34503204
http://dx.doi.org/10.3390/cancers13174394
_version_ 1783750750874107904
author Lecuelle, Julie
Boidot, Romain
Mananet, Hugo
Derangère, Valentin
Albuisson, Juliette
Goussot, Vincent
Arnould, Laurent
Tharin, Zoé
Ray Coquard, Isabelle
Ghiringhelli, François
Truntzer, Caroline
Fumet, Jean-David
author_facet Lecuelle, Julie
Boidot, Romain
Mananet, Hugo
Derangère, Valentin
Albuisson, Juliette
Goussot, Vincent
Arnould, Laurent
Tharin, Zoé
Ray Coquard, Isabelle
Ghiringhelli, François
Truntzer, Caroline
Fumet, Jean-David
author_sort Lecuelle, Julie
collection PubMed
description SIMPLE SUMMARY: High-grade serous ovarian carcinoma (HGSC) could be analyzed with a molecular stratification defined by different genomic instability signatures associated with specific mutational process and prognostic biomarkers. Immune infiltrate is known to be a robust biomarker in HGSC. We aimed to investigate immune parameters according to genomic instability signatures. We observed that homologous recombination deficiency positive, copy cumber variant signature 7 and TCR (T cells receptor) clonality are good prognostic biomarkers in HGSC. Combining TCR clonality and genomic instability signature or T cell infiltration improved the prognostic value compared to each variable taken alone. We provided a description of immune parameters according to different genomic instability signatures. We identified TCR clonality, alone or combined with genomic instability, as a promising prognostic biomarker in HGSC. ABSTRACT: Purpose: Immune infiltration is a prognostic factor in high-grade serous ovarian carcinoma (HGSC) but immunotherapy efficacy is disappointing. Genomic instability is now used to guide the therapeutic value of PARP inhibitors. We aimed to investigate exome-derived parameters to assess the tumor microenvironment according to genomic instability profile. Methods: We used the HGSC TCGA (the cancer genome atlas) dataset with genomic characteristics, including homologous recombination deficiency (HRD), copy number variant (CNV) signatures, TCR (T cell receptor) clonality and abundance of tissue-infiltrating immune and stromal cell populations. We then investigated the relationship with survival data. Results: In 578 HGSC patients, HRD status, CNV signature 7 and TCR clonality were associated with longer survival. The combination of high CNV signature 7 expression and HRD status or high CNV signature 3 expression and high TCR clonality was associated with a trend towards longer survival compared to each variable alone. Combining T cell infiltrate and TCR clonality improved the prognostic value compared to T cells infiltration alone. Prognostic value of TCR clonality was confirmed in an independent cohort. Conclusions: TCR clonality is an emerging prognostic biomarker that improves T cell infiltrate information. Analysis of TCR clonality combined with genomic instability could be an interesting prognostic biomarker.
format Online
Article
Text
id pubmed-8430641
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84306412021-09-11 TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer Lecuelle, Julie Boidot, Romain Mananet, Hugo Derangère, Valentin Albuisson, Juliette Goussot, Vincent Arnould, Laurent Tharin, Zoé Ray Coquard, Isabelle Ghiringhelli, François Truntzer, Caroline Fumet, Jean-David Cancers (Basel) Article SIMPLE SUMMARY: High-grade serous ovarian carcinoma (HGSC) could be analyzed with a molecular stratification defined by different genomic instability signatures associated with specific mutational process and prognostic biomarkers. Immune infiltrate is known to be a robust biomarker in HGSC. We aimed to investigate immune parameters according to genomic instability signatures. We observed that homologous recombination deficiency positive, copy cumber variant signature 7 and TCR (T cells receptor) clonality are good prognostic biomarkers in HGSC. Combining TCR clonality and genomic instability signature or T cell infiltration improved the prognostic value compared to each variable taken alone. We provided a description of immune parameters according to different genomic instability signatures. We identified TCR clonality, alone or combined with genomic instability, as a promising prognostic biomarker in HGSC. ABSTRACT: Purpose: Immune infiltration is a prognostic factor in high-grade serous ovarian carcinoma (HGSC) but immunotherapy efficacy is disappointing. Genomic instability is now used to guide the therapeutic value of PARP inhibitors. We aimed to investigate exome-derived parameters to assess the tumor microenvironment according to genomic instability profile. Methods: We used the HGSC TCGA (the cancer genome atlas) dataset with genomic characteristics, including homologous recombination deficiency (HRD), copy number variant (CNV) signatures, TCR (T cell receptor) clonality and abundance of tissue-infiltrating immune and stromal cell populations. We then investigated the relationship with survival data. Results: In 578 HGSC patients, HRD status, CNV signature 7 and TCR clonality were associated with longer survival. The combination of high CNV signature 7 expression and HRD status or high CNV signature 3 expression and high TCR clonality was associated with a trend towards longer survival compared to each variable alone. Combining T cell infiltrate and TCR clonality improved the prognostic value compared to T cells infiltration alone. Prognostic value of TCR clonality was confirmed in an independent cohort. Conclusions: TCR clonality is an emerging prognostic biomarker that improves T cell infiltrate information. Analysis of TCR clonality combined with genomic instability could be an interesting prognostic biomarker. MDPI 2021-08-31 /pmc/articles/PMC8430641/ /pubmed/34503204 http://dx.doi.org/10.3390/cancers13174394 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lecuelle, Julie
Boidot, Romain
Mananet, Hugo
Derangère, Valentin
Albuisson, Juliette
Goussot, Vincent
Arnould, Laurent
Tharin, Zoé
Ray Coquard, Isabelle
Ghiringhelli, François
Truntzer, Caroline
Fumet, Jean-David
TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
title TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
title_full TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
title_fullStr TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
title_full_unstemmed TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
title_short TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
title_sort tcr clonality and genomic instability signatures as prognostic biomarkers in high grade serous ovarian cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430641/
https://www.ncbi.nlm.nih.gov/pubmed/34503204
http://dx.doi.org/10.3390/cancers13174394
work_keys_str_mv AT lecuellejulie tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer
AT boidotromain tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer
AT mananethugo tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer
AT derangerevalentin tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer
AT albuissonjuliette tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer
AT goussotvincent tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer
AT arnouldlaurent tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer
AT tharinzoe tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer
AT raycoquardisabelle tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer
AT ghiringhellifrancois tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer
AT truntzercaroline tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer
AT fumetjeandavid tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer